Effect of chamomile syrup on acute leukemia
Phase 2
Recruiting
- Conditions
- Acute Lymphoblastic Leukemia (ALL).Acute lymphoblastic leukaemia [ALL]
- Registration Number
- IRCT2013021612486N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Inclusion Criteria: Pediatric (2-18 years old) ALL B cell patients admitted in Shiraz Amir hospital ; Signing written informed consent; Non-usage of any other herbal therapies.
Exclusion Criteria
Sensitivity to chamomile; Refuse to cooperate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method GCSF consumption. Timepoint: before and after the intervention. Method of measurement: Checking hospital documents.;Absolute Neutrophil Count (ANC). Timepoint: before, during, and after the intervention. Method of measurement: Calculation according to the white blood cell count and neutrophil percentage.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: before and after the intervention. Method of measurement: Standard questionnaire.;Hospital course duration. Timepoint: after the intervention. Method of measurement: Hospital documents.